Hospitalization Costs Associated With Liver Cirrhosis
نویسندگان
چکیده
منابع مشابه
Hepatic myelopathy associated with advanced liver cirrhosis.
A 41-year-old man was admitted to our institution with inertia of both lower extremities and walking instability. The patient had been diagnosed with chronic hepatitis B (hepa B) for 10 years, including hepa B virus associated cirrhosis within the last 4 years. The patient had also suffered hepatic encephalopathy within the last 6 months, which resolved following treatment. A month before the c...
متن کاملHospitalization costs associated with homelessness in New York City.
BACKGROUND Homelessness is believed to be a cause of health problems and high medical costs, but data supporting this association have been difficult to obtain. We compared lengths of stay and reasons for hospital admission among homeless and other low-income persons in New York City to estimate the hospitalization costs associated with homelessness. METHODS We obtained hospital-discharge dat...
متن کاملThe Increased Level of Serum p53 in Hepatitis B-Associated Liver Cirrhosis
Background: The ability of tumour suppressor protein p53 (P53) to regulate cell cycle processes can be modulated by hepatitis B virus (HBV). While preliminary evidences indicates the involvement of protein-x of HBV (HBx) in altering p53 DNA binding, no further data have been accumulated for the significance of serum p53 in chronic hepatitis B virus infected patients. Methods: 72 non-cirrhotic a...
متن کاملPatients with Liver Cirrhosis
.. Objective: To determine the frequency and severity of hypoglycemia in patients with liver cirrhosis. Study Design: Cross sectional case series study. Period: Six months. Setting: Liaquat University Hospital Hyderabad. Methods: All the patients of liver cirrhosis, of >12 years of age and of either gender were evaluated for hypoglycemia by assessing the glycemic status through random or fastin...
متن کاملManagement of HCV-Associated Liver Cirrhosis.
BACKGROUND Treatment of chronic hepatitis C infection is most urgent in patients with severe liver fibrosis and cirrhosis because of the high risk of decompensation, hepatocellular carcinoma, and consecutively death. The development and approval of several direct-acting antiviral drugs (DAA) in the past years has revolutionized antiviral therapy especially for patients with liver cirrhosis. M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2014
ISSN: 1098-3015
DOI: 10.1016/j.jval.2014.08.812